+20.1%
GSK vs DTE
+1.0%
+19.2%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DTE | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -1.3% | +1.3% | +0.5% |
| 7D | -3.5% | -2.6% | -1.0% | -2.7% |
| 30D | -3.4% | -4.4% | +0.9% | -2.0% |
| 3M | -8.1% | -8.3% | +0.2% | -5.0% |
| 6M | -11.1% | -8.1% | -3.1% | -7.8% |
| YTD | +0.7% | +4.4% | -3.7% | +2.7% |
| 1Y | +20.1% | +0.2% | +20.0% | +22.4% |
| All | +20.1% | +1.0% | +19.2% | +22.4% |
Cumulative growth
Daily Returns
Daily percentage return beside DTE.
Daily Out/Under-Performance
Portfolio return minus DTE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DTE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DTE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling